# Sacrosidase (Sucraid)

Source: https://ourhealthnetwork.com/drugs/sacrosidase
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Sacrosidase?

Sacrosidase (brand name: Sucraid) is a sucrose-specific enzyme. It is prescribed to treat digestive system diseases, congenital abnormalities. Across the United States, 148 doctors prescribe Sacrosidase to approximately 157 Medicare patients.

## Brand names

Sucraid

## Indications

Sacrosidase is prescribed for the treatment of digestive system diseases and congenital abnormalities.

## Conditions treated

- [Digestive System Diseases](https://ourhealthnetwork.com/conditions/digestive-system-diseases)
- [Congenital Abnormalities](https://ourhealthnetwork.com/conditions/congenital-abnormalities)

## Mechanism of action

Sacrosidase belongs to a class of medications known as sucrose-specific enzyme [epc]s.

## Drug classification

- Established Pharmacologic Class: Sucrose-specific Enzyme [EPC]
- Route of administration: ORAL

## Common side effects

abdominal pain (4), vomiting (3), nausea (2), diarrhea (2), constipation (2), insomnia (1), headache (1), nervousness (1)

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)